Ivory Investment Management LLC Has $56.33 Million Stake in CVS Health Corp (CVS)

Share on StockTwits

Ivory Investment Management LLC trimmed its holdings in CVS Health Corp (NYSE:CVS) by 21.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 875,358 shares of the pharmacy operator’s stock after selling 245,900 shares during the period. CVS Health accounts for 11.4% of Ivory Investment Management LLC’s holdings, making the stock its 2nd largest position. Ivory Investment Management LLC’s holdings in CVS Health were worth $56,329,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Camarda Financial Advisors LLC acquired a new stake in shares of CVS Health in the second quarter valued at approximately $102,000. Kiley Juergens Wealth Management LLC acquired a new stake in shares of CVS Health in the second quarter valued at approximately $103,000. Quantbot Technologies LP acquired a new stake in shares of CVS Health in the first quarter valued at approximately $103,000. Legacy Advisors LLC raised its position in shares of CVS Health by 7,100.0% in the second quarter. Legacy Advisors LLC now owns 1,800 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 1,775 shares in the last quarter. Finally, Squar Milner Financial Services LLC acquired a new stake in shares of CVS Health in the second quarter valued at approximately $122,000. Institutional investors own 83.57% of the company’s stock.

Several research analysts have commented on the stock. ValuEngine downgraded shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, September 4th. Mizuho restated a “buy” rating on shares of CVS Health in a research report on Saturday, June 30th. Royal Bank of Canada lowered their price objective on shares of CVS Health to $84.00 and set an “outperform” rating for the company in a research report on Friday, June 29th. Morgan Stanley lowered their price objective on shares of CVS Health from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Tuesday, July 3rd. Finally, Leerink Swann set a $80.00 price objective on shares of CVS Health and gave the company an “outperform” rating in a research report on Thursday, August 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company’s stock. CVS Health has a consensus rating of “Buy” and an average price target of $86.04.

In other CVS Health news, EVP Kevin Hourican sold 8,564 shares of the business’s stock in a transaction on Monday, August 27th. The shares were sold at an average price of $75.00, for a total transaction of $642,300.00. Following the sale, the executive vice president now owns 12,135 shares of the company’s stock, valued at $910,125. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.53% of the company’s stock.

NYSE CVS opened at $76.91 on Friday. The firm has a market cap of $78.72 billion, a price-to-earnings ratio of 11.73, a P/E/G ratio of 1.04 and a beta of 1.01. CVS Health Corp has a fifty-two week low of $60.14 and a fifty-two week high of $84.00. The company has a current ratio of 2.34, a quick ratio of 1.87 and a debt-to-equity ratio of 1.73.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, topping analysts’ consensus estimates of $1.61 by $0.08. The firm had revenue of $46.71 billion for the quarter, compared to analysts’ expectations of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company’s revenue was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.33 earnings per share. sell-side analysts predict that CVS Health Corp will post 7.05 earnings per share for the current year.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: What does RSI mean?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.